CYP2C19 Spartan Bioscience Taps Cardinal Health as US Distributor of CYP2C19 Genotyping Assay The new distribution partnership is for the US acute care market where, until now, Spartan was selling directly. Spartan Bioscience, Angiocare Ink Distribution Deal for CYP2C19 Test Spartan's test is for the rapid, near-patient determination of a cardiac patient's genotype for aid in determining appropriate antiplatelet treatment. Despite Challenges in the Field, GnomeDx Sees Right Time to Launch New PGx Company Premium Operating since the beginning of the year in a pilot mode, the company officially launched its comprehensive PGx testing service last week. New Analysis Examines Financial Impact of Genotyping Patients to Guide Anti-Platelet Therapy Premium The latest analysis of CYP2C19 genotyping to guide antiplatelet therapy tries to address cost questions from the vantage of a payor or large healthcare system. Canon USA Invests in Spartan Bioscience The investment will fund the research and development of new diagnostic testing products, including rapid genetic testing. Oct 30, 2014 Health Canada Approves Spartan's Rapid CYP2C19 Test for 'Near Patient' Use Nov 20, 2013 In Prescribing Study, Few Doctors Altered Treatment for Poor Plavix Metabolizers Based on Genotype Premium Oct 23, 2013 Transgenomic Enlists PDI to Market Cardiac PGx Test; PDI Entering MDx Space Premium Sep 12, 2013 Mount Sinai Group Publishes Allele-Specific PCR Assay for Novel CYP2C19 Variants Premium Aug 29, 2013 FDA Clearance of Spartan Assay Inches CYP2C19 Genotyping Closer to Point of Care Premium Aug 21, 2013 After Plavix PGx Experience, UF Rolling Out Similar Genetic Testing Program to Community Settings Premium Jan 10, 2013 Dx Focus: Akonni TruDiagnosis Studies; Spartan Bio CYP2C19 Test; Mitomics Prostate Cancer Assay Premium Dec 20, 2012 Dx Focus: Quidel AmpliVue C. Difficile; Spartan Bioscience CYP2C19 Test Starts Clinical Trial Premium Jun 28, 2012 U of Florida PGx Program Adopts Life Tech OpenArray Assays to Screen Catheterization Patients Premium Jun 27, 2012 UF to Genotype All Comers at Cath Lab to Personalize Treatment with Plavix, Eventually Other Drugs Premium Mar 28, 2012 FDA Disputes Claims that it Prematurely Updated Plavix Label with PGx Information Premium Dec 8, 2011 Spartan Bioscience Begins Italian Trial for CYP2C19 DNA Test Premium Nov 30, 2011 Canadian Team Validates Spartan's Point-of-Care CYP2C19 Test to Personalize Anti-Platelet Treatment Premium Nov 17, 2011 Canadian Trial Validates Spartan Bioscience's Point-of-Care Platform for PGx Applications Premium Nov 2, 2011 Study Finds Genomic/Clinical Combo to Be Best Predictor of Complications in Stent Patients on Plavix Premium Jul 13, 2011 FDA's Rx/Dx Draft Guidance Urges Simultaneous Development, but Addresses Alternative Scenarios Premium May 18, 2011 Medco to Evaluate Clinical Utility of AssureRx's PGx Test in Guiding Psychiatric Treatment Premium Mar 23, 2011 Celera Will Add to Quest's MDx Capabilities; But Reimbursement Questions Cloud Revenue Contribution Premium Mar 17, 2011 Quest's Focus Dx, Scripps Developing Plavix-Response Test for 3M Integrated Cycler Premium Jan 13, 2011 Spartan Bioscience Taps Germany's Alere to Distribute CYP2C19 Testing Platform Premium Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.